Blog

Gilead, Bristol-Myers Declare Direct Buyers Antitrust Suit Far Too Late

Gilead, Bristol-Myers Declare Direct Buyers Antitrust Suit Far Too Late Gilead Sciences and Bristol-Myers Squibb urged A california federal judge Thursday to nix direct buyers’ claims alleging the pharmaceutical businesses engaged in anti-competitive conduct to block generic competition and keep HIV medicine costs artificially high, arguing the matches ought to be delivered to arbitration or… Read more